FMII
ALNY icon

Farmers & Merchants Investments Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9
Closed -$2.14K – 1745
2022
Q4 		$2.14K Buy
+9
New +$1.92K ﹤0.01% 1046
2021
Q4 		– Sell
-4
Closed -$1K – 985
2021
Q3 		$1K Buy
+4
New +$750 ﹤0.01% 925

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Farmers & Merchants Investments Inc's ALNY Position: Q1 2023 in Review

Farmers & Merchants Investments Inc sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2023, closing a stake of 9 shares — an estimated $2.14K sold.

Farmers & Merchants Investments Inc first reported a position in ALNY in Q3 2021 and held it in 2 quarters. The position peaked at $2.14K in Q4 2022. 477 funds tracked by Wall St. Rank hold ALNY as of Q1 2023.

  • Farmers & Merchants Investments Inc reported no remaining Alnylam Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 9 Alnylam Pharmaceuticals shares in Q1 2023, an estimated $2.14K.
  • Farmers & Merchants Investments Inc first reported a position in Alnylam Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Farmers & Merchants Investments Inc's Alnylam Pharmaceuticals position peaked at $2.14K in Q4 2022.
  • 477 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q1 2023, filed 12 May 2023.